Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Zhejiang Hisern Medical Device CoBJSE:920166 20 Return-on-Tangible-Equity is 13.69% as of Jun. 2026, which is 57% below its 10-year median of 31.65. GuruFocus rates BJSE:920166 with a GF Score™ of 20/100. The stock has 1 warning sign investors should review. Among 756 Medical Devices & Instruments companies, Zhejiang Hisern Medical Device Co ranks better than 79.1% on this metric.
The historical rank and industry rank for Zhejiang Hisern Medical Device Co's Return-on-Tangible-Equity or its related term are showing as below:
BJSE:920166'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 17.48 Med: 31.65 Max: 42.41
Current: 17.48
During the past 4 years, Zhejiang Hisern Medical Device Co's highest Return-on-Tangible-Equity was 42.41%. The lowest was 17.48%. And the median was 31.65%.
BJSE:920166's Return-on-Tangible-Equity is ranked better than 79.1% of 756
companies
in the Medical Devices & Instruments industry
Industry Median: 4.965
vs BJSE:920166: 17.48
Zhejiang Hisern Medical Device Co (BJSE:920166) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Zhejiang Hisern Medical Device Co Return-on-Tangible-Equity Related Terms
Zhejiang Hisern Medical Device Co Return-on-Tangible-Equity Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zhejiang Hisern Medical Device Co Return-on-Tangible-Equity Chart
BJSE:920166 vs ABT, SYK, MDT: Return-on-Tangible-Equity Comparison
For the Medical Devices subindustry, Zhejiang Hisern Medical Device Co's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zhejiang Hisern Medical Device Co Return-on-Tangible-Equity vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Zhejiang Hisern Medical Device Co's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Zhejiang Hisern Medical Device Co's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Jun. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 13.69% mean?
Zhejiang Hisern Medical Device Co (BJSE:920166) has a Return-on-Tangible-Equity of 13.69% as of Jun. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Zhejiang Hisern Medical Device Co and its competitors. This is 57% below median its historical median of 31.65. Over the past decade, Zhejiang Hisern Medical Device Co's Return-on-Tangible-Equity has ranged from 17.48 to 42.41. According to the industry distribution chart, Zhejiang Hisern Medical Device Co ranks #158 out of 756 companies in the Medical Devices & Instruments industry, placing it in the top 20.9%.
Is Zhejiang Hisern Medical Device Co's Return-on-Tangible-Equity too high?
Zhejiang Hisern Medical Device Co's current Return-on-Tangible-Equity of 13.69% is 57% below median its 10-year median of 31.65. Over the past 10 years, this metric has ranged from a low of 17.48 to a high of 42.41. The Medical Devices & Instruments industry median Return-on-Tangible-Equity is 4.97. Zhejiang Hisern Medical Device Co's value of 13.69% is 175.7% above this industry median. Based on the distribution chart, Zhejiang Hisern Medical Device Co ranks #158 out of 756 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Zhejiang Hisern Medical Device Co has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Zhejiang Hisern Medical Device Co's Return-on-Tangible-Equity compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Zhejiang Hisern Medical Device Co ranks #158 out of 756 companies for Return-on-Tangible-Equity. This places Zhejiang Hisern Medical Device Co in the top 21% of its industry — outperforming the majority of peers. The industry median Return-on-Tangible-Equity is 4.97. Zhejiang Hisern Medical Device Co's value of 13.69% is 175.7% above this benchmark. Historically, Zhejiang Hisern Medical Device Co's own Return-on-Tangible-Equity has ranged from 17.48 to 42.41 over the past decade. While the company's 10-year median is 31.65 vs. the industry median of 4.97, Zhejiang Hisern Medical Device Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Medical Devices & Instruments company?
The median Return-on-Tangible-Equity among Medical Devices & Instruments companies is 4.97, based on 756 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Zhejiang Hisern Medical Device Co's current Return-on-Tangible-Equity of 13.69% is 175.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Zhejiang Hisern Medical Device Co and its competitors. For the Medical Devices & Instruments industry, the median Return-on-Tangible-Equity is 4.97 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Zhejiang Hisern Medical Device Co's current Return-on-Tangible-Equity is 13.69%, which is 57% below median its own 10-year median of 31.65. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zhejiang Hisern Medical Device Co stock overvalued right now?
Zhejiang Hisern Medical Device Co (BJSE:920166) has a current Return-on-Tangible-Equity of 13.69%. The current Return-on-Tangible-Equity is 13.69%, which is 57% below median its 10-year median of 31.65 and 175.7% above the Medical Devices & Instruments industry median of 4.97. Zhejiang Hisern Medical Device Co's overall GF Score™ is 20/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Zhejiang Hisern Medical Device Co (BJSE:920166), the current Return-on-Tangible-Equity is 13.69% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Zhejiang Hisern Medical Device Co Ltd is engaged in the research and development, manufacturing, and sale of anesthesia and patient monitoring medical devices. The company's offerings include Analgesic series products, airway and respiratory management series products, spinal canal and nerve block series products and carbon dioxide absorber series products for anesthesia machines.
20GF Score
Get the complete analysis for BJSE:920166
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BJSE:920166 has been successfully added to your 
